MARITIME Trademark

Trademark Overview


On Monday, November 18, 2024, a trademark application was filed for MARITIME with the United States Patent and Trademark Office. The USPTO has given the MARITIME trademark a serial number of 98858995. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 28, 2025. This trademark is owned by Amgen Inc.. The MARITIME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical preparations; research and development of pharmaceutical preparations in the field of weight reduction, long term weight loss management, and diabetes; medical and scientific research information in clinical trials in the field of weight reduction, long term weight loss management, and diabetes; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of weight reduction, long term weight loss management, and diabetes; providing websites featuring medical and scientific research information about pharmaceuticals preparations in the field of weight reduction, long term weight loss management, and diabetes; providing websites that features non-downloadable computer software that enables users to access, manage, update and display electronic databases in the field of weight reduction, long term weight loss management, and diabetes
maritime

General Information


Serial Number98858995
Word MarkMARITIME
Filing DateMonday, November 18, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


Goods and ServicesResearch and development of pharmaceutical preparations; research and development of pharmaceutical preparations in the field of weight reduction, long term weight loss management, and diabetes; medical and scientific research information in clinical trials in the field of weight reduction, long term weight loss management, and diabetes; providing websites featuring medical and scientific research information about the diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of weight reduction, long term weight loss management, and diabetes; providing websites featuring medical and scientific research information about pharmaceuticals preparations in the field of weight reduction, long term weight loss management, and diabetes; providing websites that features non-downloadable computer software that enables users to access, manage, update and display electronic databases in the field of weight reduction, long term weight loss management, and diabetes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 18, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320-1799

Trademark Events


Event DateEvent Description
Monday, November 18, 2024NEW APPLICATION ENTERED
Monday, November 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 31, 2024ASSIGNED TO EXAMINER
Monday, January 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED